CeQur, Inc.
Developer and commercial manufacturer of a single-use, wearable subcutaneous mealtime insulin delivery patch. The company designs, clinically evaluates, obtains regulatory clearances, and commercializes a 4-day wearable bolus insulin device; provides patient and healthcare-professional training, payer access support, and supplier/manufacturing scale-up activities.
Industries
N/A
Nr. of Employees
small (1-50)
Products
4-day wearable mealtime insulin patch (single‑use)
A single‑use, adhesive wearable device designed to deliver rapid‑acting mealtime (bolus) insulin in 2‑unit increments, intended for up to four days of wear and compatibility with U‑100 rapid‑acting insulin vials filled at time of use.
4-day wearable mealtime insulin patch (single‑use)
A single‑use, adhesive wearable device designed to deliver rapid‑acting mealtime (bolus) insulin in 2‑unit increments, intended for up to four days of wear and compatibility with U‑100 rapid‑acting insulin vials filled at time of use.
Services
Supply of a patient starter kit (includes reusable inserter and initial patches), quick-start guides, and training videos to support first‑use and onboarding.
Phone and email-based patient support team offering training, replacement inserter coordination, and benefit-navigation assistance.
HCP-facing training including quick-start videos, user guides, EHR prescription templates, refill fax forms, and in-office training support.
Pharmacy copay savings card and payer engagement resources to assist commercially insured patients with out-of-pocket costs and to confirm Medicare Part D coverage.
Support and procurement availability through government contracting partners and marketplaces for VA/GSA and related channels.
Supply of a patient starter kit (includes reusable inserter and initial patches), quick-start guides, and training videos to support first‑use and onboarding.
Phone and email-based patient support team offering training, replacement inserter coordination, and benefit-navigation assistance.
HCP-facing training including quick-start videos, user guides, EHR prescription templates, refill fax forms, and in-office training support.
Pharmacy copay savings card and payer engagement resources to assist commercially insured patients with out-of-pocket costs and to confirm Medicare Part D coverage.
Support and procurement availability through government contracting partners and marketplaces for VA/GSA and related channels.
Expertise Areas
- Wearable insulin delivery device development
- Clinical trial management and outcomes evaluation
- Regulatory compliance (FDA 21 CFR 820, ISO 13485) and QMS
- Medical device manufacturing scale-up and automation
Key Technologies
- Wearable subcutaneous bolus delivery
- Flexible microcannula insertion
- Mechanical two-button dosing with tactile/audible feedback
- Automated manufacturing and automated assembly
News & Updates
Announcement that the wearable insulin patch has replaced 10 million mealtime injections and highlights continued commercial expansion.
Equity financing round to support commercial expansion, scaling of commercial teams, and outreach initiatives.
Regulatory clearance authorizing the device for up to 4 days of wear.
Series C financing to support commercialization and scale-up of automated manufacturing for the wearable insulin-delivery device.
Announcement that the wearable insulin patch has replaced 10 million mealtime injections and highlights continued commercial expansion.
Equity financing round to support commercial expansion, scaling of commercial teams, and outreach initiatives.
Regulatory clearance authorizing the device for up to 4 days of wear.
Series C financing to support commercialization and scale-up of automated manufacturing for the wearable insulin-delivery device.